top of page

26% OFF

Rectal cancer

Bevacizumab 400mg for Rectum

Composition: Bevacizumab

Manufacturer: Roche

Dosage: 400mg

Description

Anti-VEGF for metastatic colorectal cancer as first-line therapy.

Prescription required: This medication requires a valid prescription.


Bevacizumab 400mg for Rectum

€17,200.00 Regular Price
€12,800.00Sale Price
Quantity
    bottom of page